Protein A Resin Market Analysis and Forecast to 2031: By Application (Immunoprecipitation, Antibody Purification), By Product (Natural Protein A, Recombinant Protein A), By Matrix Type (Agarose-based Matrix, Glass or Silica Gel-based Matrix, Organic Polymer-based Matrix), By End-use (Biopharmaceutical Companies, Clinical Research Laboratories, Academic Research Institutes, Contract Research Organizations) and Region
The global protein A resin market was valued at USD 1.2 billion in 2021 and it is anticipated to grow up to USD 3.0 billion by 2031, at a CAGR of 9.6% during the forecast period.
Protein A resins are the most frequently used affinity resins in biomanufacturing. Protein A chromatography is a very efficient purification procedure and is used as a capture step due to its specificity. Depending on the intended use for the target molecule (antibodies for diagnostic testing) Protein A capturing could be the sole chromatographic step required to achieve adequate product purity.
Global Protein A Resin Market Scope and Report Structure
| Report Attribute | Details |
|---|---|
| Market Size in 2021 | $1.2 bn |
| Market Size in 2031 | $3.0 bn |
| Growth Rate (2021-31) | 9.6% |
| Historic Period | 2015-2020 |
| Forecast Period | 2022-2031 |
| Base Year | 2021 |
| Segments Covered | Product, Application, Matrix, End-use |
| Key Companies | GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US) |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Trends and Drivers
Ongoing surge in antibody engineering worldwide will propel protein A resins market growth. Growing investment in synthetic biology and increasing focus on drug development by biotechnology and pharmaceutical companies will propel the industry growth. Biopharmaceutical industry are extensively using protein engineered products in their research activities to develop broad range of protein-based drugs. Therefore, rising use of chromatography in drug discovery and research industry will propel the market growth over the forecasted time period. Increasing demand of monoclonal antibodies (mAb) globally for the better treatment of chronic diseases and increasing number of pharmaceutical and biotechnology companies will boost the overall protein A resins industry growth. With better treatment options with the help of immunotherapy, the adoption will also surge. However, high cost associated with product may hinder market opportunities during the analysis timeframe.
Market Restraints and Challenges
High cost of resins may impede the market growth. Protein A resins cost around 5-10 times more than other types of resins. Though there are no alternative techniques that can achieve purification levels as high as protein A resins, their high cost makes end users look for alternatives. Some of the techniques that provide acceptable levels of purification include both chromatography and non-chromatography methods. mAb crystallization and precipitation by polyethylene glycol (PEG) precipitation are being explored as alternatives for protein A chromatography. The impact of this restraining factor is more evident in emerging markets such as APAC and Latin America. However, with the entry of new market players, the cost of protein A resins is expected to come down significantly. The increasing pressure on major market players is expected to result in price reduction, as small market entrants are offering resins at far lower prices, while simultaneously offering comparable product quality.
Global Protein A Resin Market Segmental Overview
The report analyses the global protein A resin market based on product, application matrix type, end use, and region.
Global Protein A Resin Market by Product
Based on product, it is segmented into natural protein A and recombinant protein A. Recombinant protein A resins market for significant CAGR during the forecast period. Recombinant proteins are used to prepare nanoparticles for protein drug carrier. Thus, with expanding innovation in drug discovery, the market demand will increase through 2026. Recombinant protein A is mainly used to improve solubility and to normalise sensitivity of alkaline solutions. With expanding pharmaceuticals industry and increasing technological advancements in novel drug development, the segment will proceed at significant rate.
Global Protein A Resin Market by Application
Based on application, segmented into immunoprecipitation and antibody purification. The antibody purification segment dominated the global market and accounted for the largest share in 2021. Antibody purification includes specific isolation and specific enrichment of antibodies from polyclonal antibodies, ascites fluid and cell culture supernatant of monoclonal antibodies. Rising demand for monoclonal antibodies has triggered the commercial production and purification of mAb using protein A resins.
Global Protein A Resin Market by Matrix Type
Based on matrix type, it is segmented into agarose-based matrix, glass or silica gel-based matrix and organic polymer-based matrix. Agarose-based matrix type accounted for largest revenue size in 2021. It is gaining massive popularity and will continue to show growth due to wide use in pharmaceutical and biotechnology industry. Owing to its high gelling strength at low concentrations, anti-convection medium for gel electrophoresis, suitable pH range and superior mechanical strength, this segment will witness positive growth.
Global Protein A Resin Market by End-use
Based on end-use, it is segmented into biopharmaceutical companies, clinical research laboratories, academic research institutes and contract research organizations. The biopharmaceutical companies segment dominated the market in 2021. Due to rising prevalence of various chronic diseases and increasing demand of better treatment methods, biopharmaceutical industry will foresee high demand for protein A resins. Increasing demand for protein engineering with various advancements will further boost segmental growth. Growing application in chromatography in biopharmaceutical industry will also provide substantial segment growth.
Geographical Analysis of Global Protein A Resin Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest regional market in protein A resin market. Regional growth is mainly attributed to presence of major market players constantly investing into research and development activities. Furthermore, rising prevalence of autoimmune and orphan diseases and increasing demand of better treatment methods will boost the regional market growth in the region. Presence of major industry players in the U.S. and increasing incidence of chronic diseases will favor the U.S. protein A resins market growth. Moreover, growing demand of technologically advanced products in this country will highly impact the market growth. Furthermore, increasing drug delivery and development will offer positive market growth in the country.
Major Players in the Global Protein A Resin Market
The key players in the market are GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), and PerkinElmer (US) among others.
COVID-19 Impact
The COVID-19 pandemic had a moderately positive effect on the sales of Protein A resin market. For the past 30 years, monoclonal antibodies have transformed the way we treat various diseases they have proven to be more effective, better tolerated, and easier to deliver than other treatments. Researchers are optimistic that monoclonal antibodies could help prevent and treat early infections of COVID-19. Several monoclonal antibodies that are licensed or in development for other diseases are in clinical trials for COVID-19. One of these is adalimumab, used to treat arthritis and Crohn’s disease; the University of Oxford recently launched a trial to look at its potential to treat people in care homes, funded by the COVID-19 Therapeutics Accelerator. Eli Lilly and Company (US), in collaboration with AbCellera (Canada), launched the first human study of a potential COVID-19 antibody treatment in June 2020. Other safety clinical trials have followed, including studies by AstraZeneca (UK), Celltrion (South Korea), and Regeneron (US). Since protein A resin is required for the purification of antibodies, the increase in mAb production due to the current pandemic is likely to spur the growth of the protein A resin market.
Recent Developments
- In June 2022, Navigo Proteins announced launch of an exclusive affinity resin for the capture of gp64
- In February 2021, Repligen and Navigo Proteins announce the launch of an affinity resin for the purification of covid-19 vaccines.
- In June 2018, Purolite Life Sciences, a provider of chromatography resins, announced the commercialization of a new next-generation Protein A agarose resin, Praesto Jetted A50.
- In June 2017, Repligen Corporation (US) merged with Spectrum Inc. (US). This merger was aimed at accelerating the growth of its filtration business and enhancing its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing.
- In February 2017, Purolite Life Sciences collaborated with ChromaTan Corporation (US). The development increased the production of protein A resins by up to 15 times.
Frequently Asked Questions
Q1. How big is the protein A resin market market?
Ans. The global protein A resin market size was USD 1.2 billion in 2021 and is anticipated to reach USD 3.0 billion in 2031, growing at a rate of 9.6% from 2022 to 2031.
Q2. What is the protein A resin market growth rate?
Ans. The growth rate of the protein A resin market is 9.6%.
Q3. Which region holds a major market share for the sepsis diagnostics market?
Ans. North America holds a major market share of the protein A resin market in 2021.
Q4. Which segment accounted for the largest protein A resin market share?
Ans. By end user, the healthcare segment accounted for the largest protein A resin market share.
Q5. Who are the key players in the sepsis diagnostics market?
Ans. The global protein A resin market report includes players such as GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), and PerkinElmer (US) among others.
Q6. What are the factors driving the protein A resin market growth?
Ans. The major factors driving the growth of the market are the rising incidence of HAI’s across the globe.
Q7. What are the key growth strategies of protein A resin market players?
Ans. The key growth strategies of protein A resin market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the protein A resin market during the forecast period?
Ans. The Asia-Pacific region will provide more business opportunities for the protein A resin market during the forecast period.
Table of Contents
Chapter 1. Market Introduction
1.1. Objectives of The Study
1.2. Market Definition And Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of The Market
Chapter 3. Protein A Resin Market Outlook
3.1. Protein A Resin Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. Pestle Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of The Russia And Ukraine War on The Sepsis Diagnostics Market
Chapter 4. The Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID-19 on The Sepsis Diagnostics Market
4.3. Economic Impact Analysis
Chapter 5. Protein A Resin Market by Product
5.1. Market Overview
5.2. Natural protein A
5.2.1. Market Size And Forecast, 2021-2031 ($Million)
5.2.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
5.3. Recombinant protein A
5.3.1. Market Size And Forecast, 2021-2031 ($Million)
5.3.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Protein A Resin Market by Application
6.1. Market Overview
6.2. Immunoprecipitation
6.2.1. Market Size And Forecast, 2021-2031 ($Million)
6.2.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
6.3. Antibody Purification
6.3.1. Market Size And Forecast, 2021-2031 ($Million)
6.3.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Protein A Resin Market by Matrix Type
7.1. Market Overview
7.2. Agarose-based Matrix
7.2.1. Market Size And Forecast, 2021-2031 ($Million)
7.2.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
7.3. Glass Or Silica Gel-based Matrix
7.3.1. Market Size And Forecast, 2021-2031 ($Million)
7.3.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
7.4. Organic Polymer-based Matrix
7.4.1. Market Size And Forecast, 2021-2031 ($Million)
7.4.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
Chapter 8. Protein A Resin Market by End-use
8.1. Market Overview
8.2. Biopharmaceutical Companies
8.2.1. Market Size And Forecast, 2021-2031 ($Million)
8.2.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
8.3. Clinical Research Laboratories
8.3.1. Market Size And Forecast, 2021-2031 ($Million)
8.3.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
8.4. Academic Research Institutes
8.4.1. Market Size And Forecast, 2021-2031 ($Million)
8.4.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
8.5. Contract Research Organizations
8.5.1. Market Size And Forecast, 2021-2031 ($Million)
8.5.2. Market Size And Forecast, by Region, 2021-2031 ($Million)
Chapter 9. Sepsis Diagnostics Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends And Opportunities
9.2.2. North America Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.2.3. North America Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.2.4. North America Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.2.5. North America Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.2.6. North America Protein A Resin Market Size And Forecast by Country, 2021-2031, ($Million)
9.2.7. The U.S.
9.2.7.1. The U.S. Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.2.7.2. The U.S. Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.2.7.3. The U.S. Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.2.7.4. The U.S. Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.2.8. Canada
9.2.8.1. Canada Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.2.8.2. Canada Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.2.8.3. Canada Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.2.8.4. Canada Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.2.9. Mexico
9.2.9.1. Mexico Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.2.9.2. Mexico Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.2.9.3. Mexico Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.2.9.4. Mexico Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3. Europe
9.3.1. Key Market Trends And Opportunities
9.3.2. Europe Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.3. Europe Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.4. Europe Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.5. Europe Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.6. Europe Protein A Resin Market Size And Forecast by Country, 2021-2031, ($Million)
9.3.7. Germany
9.3.7.1. Germany Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.7.2. Germany Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.7.3. Germany Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.7.4. Germany Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.8. France
9.3.8.1. France Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.8.2. France Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.8.3. France Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.8.4. France Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.9. U.K
9.3.9.1. U.K. Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.9.2. U.K. Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.9.3. U.K. Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.9.4. U.K. Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.10. Spain
9.3.10.1. Spain Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.10.2. Spain Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.10.3. Spain Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.10.4. Spain Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.11. Italy
9.3.11.1. Italy Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.11.2. Italy Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.11.3. Italy Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.11.4. Italy Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.12. Russia
9.3.12.1. Russia Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.12.2. Russia Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.12.3. Russia Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.12.4. Russia Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.3.13. Rest of Europe
9.3.13.1. Rest of Europe Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.3.13.2. Rest of Europe Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.3.13.3. Rest of Europe Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.3.13.4. Rest of Europe Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4. Asia-Pacific
9.4.1. Key Market Trends And Opportunities
9.4.2. Asia-Pacific Protein A Resin Market Size And Forecast by Country, 2021-2031, ($Million)
9.4.3. Asia-Pacific Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.4. Asia-Pacific Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.4.5. Asia-Pacific Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.6. Asia-Pacific Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4.7. China
9.4.7.1. China Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.7.2. China Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.4.7.3. China Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.7.4. China Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4.8. India
9.4.8.1. India Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.8.2. India Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.4.8.3. India Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.8.4. India Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4.9. Japan
9.4.9.1. Japan Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.9.2. Japan Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.4.9.3. Japan Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.9.4. Japan Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4.10. South Korea
9.4.10.1. South Korea Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.10.2. South Korea Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million) South Korea Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.10.3. South Korea Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.4.11. Rest of APAC
9.4.11.1. Rest of APAC Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.4.11.2. Rest of APAC Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.4.11.3. Rest of APAC Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.4.11.4. Rest of APAC Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.5. Rest of The World
9.5.1. Key Market Trends And Opportunities
9.5.2. Rest of The World Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.5.3. Rest of The World Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.5.4. Rest of The World Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.5.5. Rest of The World Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.5.6. Rest of The World Protein A Resin Market Size And Forecast by Country, 2021-2031, ($Million)
9.5.7. Latin America
9.5.7.1. Latin America Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.5.7.2. Latin America Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.5.7.3. Latin America Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.5.7.4. Latin America Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.5.8. Middle East
9.5.8.1. Middle East Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.5.8.2. Middle East Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million)
9.5.8.3. Middle East Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.5.8.4. Middle East Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
9.5.9. Africa
9.5.9.1. Africa Protein A Resin Market Size And Forecast by Product, 2021-2031, ($Million)
9.5.9.2. Africa Protein A Resin Market Size And Forecast by Application, 2021-2031, ($Million) Africa Protein A Resin Market Size And Forecast by Matrix Type, 2021-2031, ($Million)
9.5.9.3. Africa Protein A Resin Market Size And Forecast by End-use, 2021-2031, ($Million)
Chapter 10. Competitive Landscape
10.1. Market Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Developmental Strategy Benchmarking
10.3.1. New Testing Type Development
10.3.2. Chemical-based Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Joint Ventures, And Collaborations
10.3.5. Mergers And Acquisitions
Chapter 11. Company Profiles
11.1. GE Healthcare (US)
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Chemical-based offerings
11.1.4. Key Strategic Initiatives
11.1.5. SWOT Analysis
11.2. Merck Millipore (Germany)
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Chemical-based offerings
11.2.4. Key Strategic Initiatives
11.2.5. SWOT Analysis
11.3. Repligen Corporation (US)
Company Snapshot
11.3.1. Financial Performance
11.3.2. Chemical-based offerings
11.3.3. Key Strategic Initiatives
11.3.4. SWOT Analysis
11.4. T2 Thermo Fisher Scientific (US)
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Chemical-based offerings
11.4.4. Key Strategic Initiatives
11.4.5. SWOT Analysis
11.5. Tosoh Bioscience (Japan)
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Chemical-based offerings
11.5.4. Key Strategic Initiatives
11.5.5. SWOT Analysis
11.6. Purolite Corporation (US)
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Chemical-based offerings
11.6.4. Key Strategic Initiatives
11.6.5. SWOT Analysis
11.7. Novasep Holding SAS (France)
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Chemical-based offerings
11.7.4. Key Strategic Initiatives
11.7.5. SWOT Analysis
11.8. Agilent Technologies (US)
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Chemical-based offerings
11.8.4. Key Strategic Initiatives
11.8.5. SWOT Analysis
11.9. GenScript Biotech Corporation (China)
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Chemical-based offerings
11.9.4. Key Strategic Initiatives
11.9.5. SWOT Analysis
11.10. PerkinElmer (US)
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Chemical-based offerings
11.10.4. Key Strategic Initiatives
11.10.5. SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report
Key Players
Global Protein A Resin Market Segmentation
Product
- Natural protein A
- Recombinant protein A
Application
- Immunoprecipitation
- Antibody Purification
Matrix Type
- Agarose-based matrix
- Glass or Silica gel-based matrix
- Organic Polymer-based matrix
End-use
- Biopharmaceutical Companies
- Clinical Research Laboratories
- Academic Research Institutes
- Contract Research Organizations
Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of World
- Latin America
- Middle East
- Africa